Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for international trade professionals · Thursday, July 4, 2024 · 725,160,814 Articles · 3+ Million Readers

Empower Clinics Announces Resignation of Two Directors Effective Immediately

Empower Clinics Inc. (CSE:EPW)

VANCOUVER, B.C., CANADA, July 3, 2024 /EINPresswire.com/ -- Empower Clinics Announces Resignation of Two Directors Effective Immediately

EMPOWER CLINICS INC (CSE:EPW) (PINK:EPWCF)
("Empower" or the "Company"), an integrated healthcare company with a developing research and clinical trials division, announces the resignations of Directors Andrejs Bunkse and Alexis Wukich effective immediately.

"We are deeply saddened to make this announcement," McAuley stated. "I extend my heartfelt thanks to Mr. Bunkse and Ms. Wukich for their unwavering support over the past few years. Through both good times and challenging periods, they consistently demonstrated professionalism and integrity. I wish them the very best in their future endeavors."

AGORACOM for shareholder discussion, questions, and engagement with management
https://agoracom.com/ir/EmpowerClinics

ABOUT EMPOWER CLINICS

Empower Clinics Inc. is a healthcare company evolving into a leading provider of clinical trials and research solutions in the U.S. With extensive experience in health clinic management, Empower has established itself as a Site Management Organization (SMO) with active operations in large markets, including Los Angeles, CA, Dallas, TX, and Houston, TX. EPW Curesearch LLC partners with leading pharmaceutical brands and top medical specialists, facilitating phase II and phase III interventional drug trials in key therapeutic areas.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer
CONTACTS:
Steven McAuley CEO

s.mcauley@empowerclinics.com
+1 604-359-9146

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur.

Such forward-looking statements are based on assumptions known to management at this time and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including that the Financing may not be completed on the terms expected or at all, and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.

Steven McAuley
Empower Clinics Inc.
+1 604-359-9146
s.mcauley@empowerclinics.com

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release